Position in ZLAB
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$507
+$507 QoQ
Shares Held
27
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $172,897,730 across 173 Biotechnology names. ZLAB ranks #153 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,977,404 | $160,329,155 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,522 | $2,465,793 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $1,869,631 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,107 | $855,312 | |
| 5 | INCY |
Incyte Corp
|
4,919 | $462,976 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
14,020 | $456,210 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
1,688 | $436,044 | |
| 8 | ARGX |
Argenx SE
|
553 | $403,828 |
All Filings in ZLAB
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $507 | 27 | Shares | Sole | 2026-05-07 | |
| 2024-12-31 | $0 | 0 | Shares | Sole | 2025-02-10 | |
| 2021-12-31 | $42,298 | 673 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $35,832 | 340 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $56,990 | 322 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $40,829 | 306 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $27,474 | 203 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $15,136 | 182 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $9,198 | 112 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $54,311 | 1,055 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||